Sign inCreate account

Report workspace tools

NCT01912092COMPLETEDanonymous

A NON-CONTROLLED PROSPECTIVE COHORT STUDY OF THE USE OF ASKINA® CALGITROL® PASTE + STANDARD OF CARE ON MILDLY INFECTED, NON-ISCHAEMIC DIABETIC FOOT ULCERS

Sponsor

Source record

BBraun Medical SAS

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

Askina Calgitrol paste

Indication / condition

AI-normalized

Diabetic Foot Ulcer (DFU)

Intervention

Source record

Askina Calgitrol paste

Source & freshness

Source record

NCT ID

NCT01912092

Original source

ClinicalTrials.gov

Source last updated

Jul 31, 2015

Ingested at

Jun 08, 2026

Internal sync

Jun 08, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT01912092

Title

A NON-CONTROLLED PROSPECTIVE COHORT STUDY OF THE USE OF ASKINA® CALGITROL® PASTE + STANDARD OF CARE ON MILDLY INFECTED, NON-ISCHAEMIC DIABETIC FOOT ULCERS

Sponsor

BBraun Medical SAS

Status

COMPLETED

Phase

NA

Condition raw

Diabetic Foot Ulcer (DFU)

Condition normalized

Diabetic Foot Ulcer (DFU)

Modality raw

medical device

Modality normalized

medical device

Target raw

Askina Calgitrol paste

Target normalized

Askina Calgitrol paste

Interventions

Askina Calgitrol paste

Public preview

Source record

The purpose of this study is to assess the efficacy of Askina® Calgitrol® Paste in reducing local infection in subjects treated for mildly infected Diabetic Foot Ulcers (DFU) with Askina® Calgitrol® Paste.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

A NON-CONTROLLED PROSPECTIVE COHORT STUDY OF THE USE OF ASKINA® CALGITROL® PASTE + STANDARD OF CARE ON MILDLY INFECTED, NON-ISCHAEMIC DIABETIC FOOT ULCERS

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT01912092

Status

COMPLETED

Phase

NA

Sponsor

BBraun Medical SAS

Executive brief

Investment-Ready Snapshot

The purpose of this study is to assess the efficacy of Askina® Calgitrol® Paste in reducing local infection in subjects treated for mildly infected Diabetic Foot Ulcers (DFU) with Askina® Calgitrol® Paste.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedJul 31, 2015
Internal syncJun 08, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01912092

Indication

Diabetic Foot Ulcer (DFU)

Modality

medical device

Target

Askina Calgitrol paste

Intervention

Askina Calgitrol paste

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.